SS Innovations International (SSII) Other Non-Current Liabilities (2022 - 2026)
SS Innovations International (SSII) posted Other Non-Current Liabilities of $205841.0 for Q1 2026, up 96.61% sequentially from $104696.0 in Q4 2025, and up 109.87% YoY from $98078.0 in Q1 2025.
SS Innovations International (SSII) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
SS Innovations International has reported Other Non-Current Liabilities for 5 years, with the latest figure at $205841.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 109.87% year-over-year to $205841.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205841.0 (up 109.87% YoY) and the FY2025 annual result came in at $104696.0, down 81.78% from the prior year.
- Other Non-Current Liabilities climbed to $205841.0 in Q1 2026 per SSII's latest filing, from $104696.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $574603.0 in Q4 2024 and troughed at $10626.0 in Q4 2022.
- A 5-year average of $120698.9 and a median of $58391.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities jumped 1068.84% in 2024, then sank 81.78% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $10626.0 in 2022, then surged by 362.64% to $49160.0 in 2023, then surged by 1068.84% to $574603.0 in 2024, then tumbled by 81.78% to $104696.0 in 2025, then jumped by 96.61% to $205841.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $205841.0, $104696.0, and $189402.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | SS Innovations International | 731.50 Mn | 709.20 Mn | 7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 443,515.00 |
| Mar 31, 2026 | 205,841.00 |
| Dec 31, 2025 | 104,696.00 |
| Sep 30, 2025 | 189,402.00 |
| Jun 30, 2025 | 111,880.00 |
| Mar 31, 2025 | 98,078.00 |
| Dec 31, 2024 | 574,603.00 |
| Sep 30, 2024 | 58,144.00 |
| Jun 30, 2024 | 58,391.00 |
| Mar 31, 2024 | 48,358.00 |
| Dec 31, 2023 | 49,160.00 |
| Sep 30, 2023 | 30,673.00 |
| Jun 30, 2023 | 29,234.00 |
| Dec 31, 2022 | 10,626.00 |